CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 77 filers reported holding CTI BIOPHARMA CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $25,276 | -33.7% | 6,018 | -5.1% | 0.00% | – |
| Q4 2022 | $38,127 | -92.5% | 6,344 | -92.7% | 0.00% | – |
| Q3 2022 | $507,000 | – | 87,068 | +124282.9% | 0.00% | – |
| Q2 2022 | $0 | – | 70 | +311.8% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 17 | -100.0% | 0.00% | – |
| Q3 2018 | $2,051,000 | -70.6% | 949,700 | -32.2% | 0.00% | -100.0% |
| Q2 2018 | $6,972,000 | +27.7% | 1,400,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,460,000 | – | 1,400,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,904,400 | $3,355,000 | 2.31% |
| BVF INC/IL | 6,929,690 | $5,955,000 | 0.65% |
| CAXTON CORP | 324,452 | $279,000 | 0.32% |
| NEA Management Company, LLC | 3,750,000 | $3,222,000 | 0.23% |
| Orbimed Advisors | 5,000,000 | $4,297,000 | 0.07% |
| Fosun International Ltd | 459,274 | $390,000 | 0.03% |
| Paloma Partners Management Co | 229,800 | $197,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 127,602 | $110,000 | 0.00% |
| LMR Partners LLP | 54,931 | $47,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 17,495 | $15,000 | 0.00% |